Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03555903
Other study ID # 69HCL17_0813
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 1, 2018
Est. completion date February 2028

Study information

Verified date July 2021
Source Hospices Civils de Lyon
Contact François GOLFIER, MD
Phone 0478864179
Email francois.golfier@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Endometriosis is a common gynaecologic disease affecting 5 to 15% women of reproductive age and up to 40% of infertile women. It is characterized by the presence of active endometrial tissue outside the uterine cavity, potentially causing invalidating chronic pelvic pain and infertility. It is therefore crucial to limit the progression and/or recurrence of the disease, and to improve the quality of life of affected women. Deep infiltrating endometriosis (DIE), an advanced form of the disease, is defined by the invasion of an anatomical structure and organ close to the uterus (i.e. uterosacral ligament, rectovaginal space, recto-sigmoidal colon or bladder), or by a peritoneal invasion greater than 5mm. The management of DIE is unfortunately not yet based on high-level evidence data; it mainly depends on the localization of the disease, the extend of the invasion and the severity of the symptoms. In the absence of clear guidelines based on empirical data, the choice between surgical or medical treatment remains difficult and controversial. To improve optimal DIE management, the investigators aim to create a prospective database reporting on DIE surgically treated in a teaching hospital in Lyon/France (Centre hospitalier universitaire Lyon Sud) Data on known risks factors, symptoms (pain), quality of life, infertility history and disease management will be obtained using self-questionnaires, clinic, paraclinic, surgical and histological records as follow. 1. Each patient will be asked to fill in electronics protected on-line forms: the first one before surgery, followed by three follow-up forms at 1, 2 and 5 years after surgery. 2. The surgeon will be asked to fill in two electronic protected on-line forms: the first one at the time of surgery and the second one during a post-operative consultation (one month after surgery). The questionnaires used in this study are similar to those used for the Endometriosis database "CIRENDO" (explain briefly what it is), which will ultimately allow us to pool the data from the 2 databases. This French prospective study will advance the scientific knowledge on DIE surgical treatment and, by helping evaluate the impact of the surgery on the quality of life and fertility of affected women, will guide future recommendations for an optimal management of this invalidating disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date February 2028
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - surgically management for deep endometriosis Exclusion Criteria: - No surgical management necessary - Isolated Adenomyosis

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Endometriosis cohort
The investigator record data on risks factors, symptoms (pain), quality of life (using standardized quality of life questionnaires), infertility history, and management of the disease with a 5-years follow up. Different surgical procedures exist to treat DIE and are they are described in the database, to allow comparison.

Locations

Country Name City State
France Centre hospitalier Lyon sud Pierre-Bénite

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The impact of the management of deep endometriosis on the quality of life Evolution of SF 36 quality of life scores. 5 years
Primary The impact of the management of deep endometriosis on the quality of life Evolution of EHP-30 quality of life scores. 5 years
Secondary Describe endometriosis Description of the study population : Socio-demographic data 5 years
Secondary Describe risk factors of the disease. Postoperative complications (DINDO classification) 5 years
Secondary Describe diagnostic delay of the disease. Description of diagnostic. 5 years
Secondary Describe diagnostic management of the disease. Description of therapeutic management : Diagnostic loadings 5 years
Secondary Impact of the management of deep endometriosis on the use of assisted reproductive therapy. Impact on fertility. 5 years
Secondary Describe risk factors of the disease. Recurrence of endometriosis. 5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02238678 - Impact of Deep Endometriosis Surgery on Bladder Function N/A
Completed NCT03779256 - Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life